Aemetis (NASDAQ:AMTX) Shares Cross Below 200 Day Moving Average – Time to Sell?

Aemetis, Inc. (NASDAQ:AMTX) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.33 and traded as low as $2.60. Aemetis shares last traded at $2.78, with a volume of 599,676 shares trading hands.

Analyst Ratings Changes

Several research analysts have issued reports on AMTX shares. HC Wainwright restated a “buy” rating and set a $28.00 price target on shares of Aemetis in a report on Friday, August 2nd. UBS Group lowered their target price on shares of Aemetis from $8.25 to $7.75 and set a “buy” rating for the company in a research note on Monday, August 19th. StockNews.com raised shares of Aemetis to a “sell” rating in a research report on Wednesday, July 31st. Ascendiant Capital Markets lowered their price objective on Aemetis from $20.00 to $19.00 and set a “buy” rating for the company in a research report on Tuesday, September 3rd. Finally, Truist Financial restated a “hold” rating and set a $3.50 target price (down previously from $4.00) on shares of Aemetis in a research report on Wednesday, July 31st. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, Aemetis currently has an average rating of “Moderate Buy” and an average price target of $12.95.

Aemetis Stock Up 6.5 %

The company has a market capitalization of $131.22 million, a PE ratio of -2.42 and a beta of 1.24. The firm’s 50-day moving average is $2.51 and its 200-day moving average is $3.33.

Aemetis (NASDAQ:AMTX) last posted its quarterly earnings results on Thursday, August 1st. The specialty chemicals company reported ($0.66) earnings per share for the quarter, missing the consensus estimate of ($0.41) by ($0.25). The business had revenue of $66.56 million for the quarter, compared to analyst estimates of $75.37 million. During the same period in the previous year, the company earned ($0.68) earnings per share. As a group, equities research analysts predict that Aemetis, Inc. will post -2.07 EPS for the current year.

Institutional Trading of Aemetis

A number of hedge funds have recently made changes to their positions in AMTX. SG Americas Securities LLC purchased a new position in Aemetis in the 1st quarter worth approximately $60,000. Rhumbline Advisers increased its holdings in shares of Aemetis by 2,837.1% in the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after purchasing an additional 50,528 shares in the last quarter. Susquehanna Fundamental Investments LLC raised its stake in shares of Aemetis by 287.4% in the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock worth $379,000 after purchasing an additional 93,536 shares during the last quarter. State Board of Administration of Florida Retirement System bought a new position in shares of Aemetis during the first quarter valued at $84,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Aemetis during the second quarter valued at $306,000. 27.02% of the stock is owned by institutional investors.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.